Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
The Board of Directors of Financière de Tubize appoints Bruno Holthof as new Chair
-
DOVRE GROUP TRADING STATEMENT JANUARY 1 – MARCH 31, 2025
-
POSTPONEMENT OF BELIEVE'S ANNUAL GENERAL MEETING SCHEDULED FOR 26 JUNE 2025
-
Dovre Group: Final purchase price of the sold businesses
-
SMCP - Press Release - 2025 Q1 Sales
-
Transaction in Own Shares
-
Aalberts reports the progress of its share buyback programme 22 April – 25 April 2025
-
Headwall Group and Laitram Machinery Announce Deployment of Hyperspectral Technology in Food Processing
-
Heineken® Celebrates Football Fandom with a Cheers to Superstitious Fans
-
Amundi: Results for the First quarter of 2025 - Record inflows at +€31bn
-
Fingerprint Cards AB (publ) publishes interim report for January – March 2025
-
Santhera Full Year Results for the Year Ended 31 December 2024
-
Norsk Hydro: Strong upstream results, navigating global trade uncertainty
-
BAWAG Group publishes Q1 2025 results: Net profit € 201 million and RoTCE 25.8%
-
Start of Day Message
-
New data with daridorexant assessing the transition from night to day in insomnia disorder published in Sleep Medicine
-
Novartis continues strong momentum with double-digit sales growth, robust margin expansion and multiple approvals in Q1
-
Santhera Publishes Agenda for its Annual General Meeting
-
Vivoryon Therapeutics N.V. Reports Full Year 2024 Financial Results and Provides Business Update
-
Planisware - Q1 2025 revenue
-
Hexagon Purus ASA: Invitation to the presentation of first quarter 2025 results
-
Q1 2025 Revenues
-
Clariant delivers further improved profitability in challenging environment – outlook confirmed
-
Aspocomp’s Interim Report January 1-March 31, 2025: Order book, and net sales increased significantly, and the operating result turned clearly profitable
-
Rexel: First-Quarter 2025 Sales
-
Lassila & Tikanoja plc: Interim Report 1 January–31 March 2025
-
eQ Plc’s interim report Q1 2025 – eQ’s operating profit EUR 5.8 million
-
Roche granted FDA Breakthrough Device Designation for first AI-driven companion diagnostic for non-small cell lung cancer
-
Weekly progress on share repurchase program to cover share plans and reduce capital
-
Apranga Group interim report for 3 months 2025
-
Grupo Aeroportuario Del Pacifico Announces Results for the First Quarter of 2025
-
Audited annual information of AB Kauno Energija for the year 2024
-
Sanoma Corporation, Interim Report 1 January–31 March 2025: Improved performance driven by Learning in a seasonally small quarter
-
Dividend payment ex-date of AB Kauno Energija
-
Resolutions of the General Meeting of Shareholders of AB Kauno Energija
-
Lumineye Introduces Sublingual Nano-Drop Formula to Help Support Normal Eye Comfort and Clarity
-
BeyondTrust Launches Free Identity Security Risk Assessment to Reveal Hidden Paths to Privilege™
-
Experience the Best AI Girlfriend with CraveU AI
-
Girard Media LLC Expands Growth Solutions with New PR, Advertising, and Media Services to Enhance Brand Visibility and Strategic Marketing
-
Halmont Properties Corporation Year End Results
-
Mar-a-Lago Meeting Highlights Zahid F Sarder Saddi’s Call for Global Action Amid Rising Extremism in Bangladesh
-
Banco Itaú Chile Reschedules First Quarter 2025 Financial Results Conference Call
-
GBank Financial Holdings Inc. Announces Uplisting to Nasdaq Capital Market
-
Fountain Asset Corp. Announces its Financial Results for the Quarter and Year Ended December 31, 2024
-
OROCO FILES SHELF PROSPECTUS
-
Mesoblast Appoints Corporate Finance Leader Lyn Cobley To Board
-
Global Virus Network Issues Urgent Call to Action to Mitigate the Rising Threat of H5N1 Avian Influenza
-
Grupo Bafar Reports First Quarter 2025 Results
-
UK Company, Stablepharma Ltd, enters Phase 1 Clinical Trials with world-first Fridge-Free Tetanus & Diphtheria Vaccine
-
UK Company, Stablepharma Ltd, enters Phase 1 Clinical Trials with world-first Fridge-Free Tetanus & Diphtheria Vaccine
